ChemCon meets the high standards of the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) and receives drug substance accreditation for the Japanese market. Dr. Raphael Vogler, CEO & President of ChemCon, states: „We are very proud that our high German standards meet those of PMDA and look forward to establishing further direct customer relationships in Japan.”
Japanese pharmaceutical companies must ensure that drug substances imported for use on the Japanese market are produced by accredited manufacturers. The PMDA works together with the Japanese Ministry of Health, Labour and Welfare. They protect the public health by assuring the safety and quality of pharmaceuticals and medical devices.
ChemCon is looking back on an almost 20-year successful inspection history by the US Food and Drug Administration (FDA) and European agencies. The manufacturer had also been accredited by the PMDA in the past. The new Japanese accreditation confirms ChemCon’s continuous highest quality and GMP compliance.
